PHEN President and Founder Mr. Thomas A. Farrington provided closing remarks for the second session of the 2025 Prostate Cancer Disparity Summit, thanking sponsors and community partners as well as describing the next session on new treatments and clinical trials. Mr. Farrington highlighted the strong collaboration and shared mission among its partners in addressing prostate cancer in underserved communities.

He asked the audience to take a poll about this session. The survey results show that 100% of poll takers were very satisfied with this program, 94% felt that the pace of the session was just right, and 94% rated the speakers as excellent. In addition, 93% rated the panel discussion as very good and 100% liked the Zoom format.